Meghan Heberton, MD, an assistant professor of dermatology at UT Southwestern Medical Center, talks about her presentation at Masterclasses in Dermatology on the latest updates on cutaneous toxicities in Graft-versus-host (GvHD) disease.
Cutaneous Toxicities in Graft-versus-host Disease
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Meghan Heberton, MD, an assistant professor of dermatology at UT Southwestern Medical Center, talks about her presentation at Masterclasses in Dermatology on the latest updates on cutaneous toxicities in Graft-versus-host (GvHD) disease.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
Medical Therapy: Lipid Modifying Therapies
HF Management for Patients with Comorbid Conditions
Level Up Your Skills: Tailoring Management of HF
Antibody-Drug Conjugates in Bladder Cancer: Guideline Updates and Adverse Event Management
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
Exploring New and Emerging Treatments in Muscle Invasive Bladder Cancer
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?